Litcius/Paper detail

A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II)

Alexander J. Rossi, Emily A. Verbus, Mark B. Faries, Marc Moncrieff, Michael A. Henderson, Jonathan M. Hernandez, Michael Lowe

2022Annals of Surgical Oncology19 citationsDOI

Topics & Concepts

MedicineSurgical oncologyMelanomaStage (stratigraphy)Randomized controlled trialSurgical excisionSurgeryCancer researchBiologyPaleontologyCutaneous Melanoma Detection and ManagementCAR-T cell therapy researchCell Image Analysis Techniques
A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II) | Litcius